Cannabidiol (Cbd)
Brand name: Epidiolex
Rank #194 of 500 drugs by total cost
$75.5M
Total Cost
15,726
Total Claims
$75.5M
Total Cost
523
Prescribers
$4,804
Cost per Claim
403
Beneficiaries
16,482
30-Day Fills
$144K
Avg Cost/Provider
30
Avg Claims/Provider
About Cannabidiol (Cbd)
Cannabidiol (Cbd) (sold as Epidiolex) was prescribed 15,726 times by 523 Medicare Part D providers in 2023, costing the program $75.5M. At $4,804 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 191 | Lanadelumab-Flyo (Takhzyro) | $76.5M | 1,670 |
| 192 | Diltiazem Hcl (Diltiazem 24hr Er (Cd)) | $75.9M | 1,846,124 |
| 193 | Carvedilol (Carvedilol) | $75.6M | 6,390,691 |
| 194 | Cannabidiol (Cbd) (Epidiolex) | $75.5M | 15,726 |
| 195 | Eculizumab (Soliris) | $74.6M | 1,794 |
| 196 | Lidocaine (Lidocaine) | $74.4M | 416,864 |
| 197 | Simvastatin (Simvastatin) | $74.4M | 6,872,746 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology